Tilray Medical has expanded its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany at Tilray's EU‑GMP certified facility in Neumünster as part of the BfArM in‑country cultivation program.
Rajnish Ohri, Managing Director International at Tilray Brands, commented, "The expansion of our Tilray Craft premium cannabis flower range demonstrates our commitment to patient care in Germany. As a global leader in medical cannabis, supported by our advanced EU-GMP facility in Germany, Tilray continuously introduces new genetics bred to pharmaceutical standards at Neumünster. This approach enables us to provide reliable, patient-focused medical cannabis options. Our priority remains delivering consistent, quality solutions to physicians and pharmacies, always placing patients' needs first."
© Tilray Brands
Tilray Craft cannabis is cultivated and produced indoors at Tilray's EU‑GMP certified facility located in Neumünster, Germany. The production process adheres to rigorous quality control standards and protocols, ensuring distinctive, quality medical cannabis that patients can depend on for consistency and reliability.
The new products include Tilray Craft Cannabisblüten THC30 TRM (Triangle Mints), Tilray Craft Cannabisblüten THC28 TRM (Triangle Mints), Tilray Craft Cannabisblüten THC28 PPV (Platinum Pave 34), Tilray Craft Cannabisblüten THC25 PPV (Platinum Pave 34), and Tilray Craft Cannabisblüten THC22 SNS (Sunset Sherbet).
For more information:
Tilray
www.tilray.com
